Carrie Strom is Allergan’s new Senior Vice President, U.S. Medical Aesthetics, a portfolio of brands including BOTOX^® Cosmetic (onabotulinumtoxinA), JUVÉDERM^® Collection of Fillers, Natrelle^® collection of breast implants, Alloderm^®, SkinMedica^® and CoolSculpting^®. 

Strom will report to Allergan’s Chief Commercial Officer, Bill Meury.

Strom joined Allergan in 2011. Most recently she was Vice President of Marketing, Plastic Surgery and Regenerative Medicine. Strom also served as Vice President of Marketing for SkinMedica^®  leading the brand’s digital evolution to a new e-commerce platform.

“We are excited that Carrie Strom is leading our U.S. Medical Aesthetics business,” says Bill Meury, Chief Commercial Officer at Allergan, in a news release. “Carrie brings valuable experience in both the US Plastic Surgery and Dermatology businesses, along with new ideas, perspectives and approaches that will help us better serve our valued customers and their practices. In her new role, Carrie will direct the entire commercial operation for U.S. medical aesthetics with a focus on ensuring that Allergan continues to develop and introduce new and innovative products and raise consumer awareness and interest for aesthetic treatments.”

“It’s an exciting time in medical aesthetics and Allergan continues to be at the forefront of innovation and growth of the category,” Strom says. “I am excited to lead our U.S. Medical Aesthetics team as we maintain our strong record of building new markets and delivering best-in-class products. I am proud of our organization and we will continue to deliver solutions to unmet needs that support and serve our customers."